Document is current
Any future updates will be listed below
-
Authors
Davis-Marcisak, Emily F.
Fitzgerald, Allison A.
Kessler, Michael D.
Danilova, Ludmila
Jaffee, Elizabeth M.
Zaidi, Neeha
Weiner, Louis M.
Fertig, Elana J. https://orcid.org/0000-0003-3204-342X
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01CA177669)
National Institutes of Health (U01CA196390)
National Institutes of Health (U01CA212007)
National Institutes of Health (F31 CA250135-01A1)
National Institutes of Health (R01CA184926)
National Institutes of Health (P50CA062924)
National Institutes of Health (P30CA006973)
National Institutes of Health (CA50633)
National Institutes of Health (CA51008)
National Institutes of Health (F30 CA239441)
- License Information
-
More Information
Article History
Received: 8 March 2021
Accepted: 27 July 2021
First Online: 11 August 2021
Declarations
:
: Not applicable
: Not applicable
: EJF is on the Scientific Advisory Board of Viosera Therapeutics. The remaining authors declare that they have no competing interests.
